Brenmiller just announced it has signed a Memorandum of Understanding with India’s largest solar panel manufacturer Waaree Energies to deploy its thermal energy storage projects in India. This announcement marks Brenmiller’s entrance into the Indian market, the world’s second most populous country and fifth largest economy, adding to the Company’s growing global presence including Israel, Europe, and the U.S.

It has been 50 years since the FDA approved a new treatment for advanced primary head and neck cancer. CEL-SCI recently announced progress on the regulatory approval front. Approval for Multikine is being pursued in markets including the U.S., Europe, the United Kingdom, and Canada.

Mobilicom just announced expansion into new geographic markets and its 48th design win – meaning its technologies have been integrated as key components into 48 new autonomous robotics and drone systems that are moving toward commercial scale production.

Pluri recently announced a $4.2 million contract from the U.S. National Institutes of Health to advance the development of its PLX-R18 cell therapy to treat hematopoietic acute radiation syndrome, a deadly disease that can result from nuclear disasters and radiation exposure.